Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...

The FDA has approved a new at-home test for common sexually transmitted infections and diseases. The test for chlamydia, ...

In the midst of tariff mayhem this week, finally some good news has landed, with Orthocell gaining a big FDA approval win in ...

Many states don’t tax synthetic nicotine products like Zyn, but Washington might start after House Democrats advanced a bill ...

Shuren, who retired from his spot leading the FDA’s Center for Devices and Radiological Health (CDRH) in 2024, said last week ...

Having won US Food & Drug Administration approval for its novel nerve repair agent Remplir, Orthocell is wasting no time ...

A surge of generics, biosimilars, and innovative therapies is expected in 2025, addressing conditions from cancer to chronic ...

Post Liberation Day, life science companies are clarifying the likely impact of Trump's tariffs – and the news is largely positive.

A recent study found broad public support for the use of artificial intelligence in healthcare, but participants did express ...

The Food and Drug Administration (FDA) has granted accelerated approval to Vanrafia ® (atrasentan) to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk of rapid ...

Shortly after Donald Trump picked Robert F. Kennedy Jr. to lead his health department, a group of pharmaceutical executives ...

In Actavis Labs. FL, Inc. v. U.S.  (“Actavis”), a recent precedential decision, the Federal Circuit answered an important ...